IP Library Granted Patent US 12,043,836
Granted Patent B2
US 12,043,836 · App. 17/039,839 · Granted Jul 23, 2024

RNA-guided endonuclease expressing algal strain for high efficiency in vivo genome editing

Inventors: John Verruto (San Diego, CA); Eric Moellering (San Diego, CA)
Assignee: Viridos, Inc.
C12N15/8213C12N9/1241C12N9/22C12N15/8209C12N15/8216C12N15/85C12N15/90C12N15/905C12N15/907C12Y207/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,043,836
App. No.
17/039,839
Granted
Jul 23, 2024
Kind
B2
Abstract

The present invention provides cell lines for high efficiency genome editing using cas/CRISPR systems, methods of generating such cells lines and methods of generating mutations in the genome of an organism using such cell lines.

Claims (24)

1. A fully penetrant RNA-guided endonuclease expressing algal strain of the Class Trebouxiophyceae comprising:

a Cas protein expression construct comprising:

a Cas nuclease expression cassette;

a repressible CRE expression cassette comprising a Cre coding region; and

a selectable marker cassette;

a reporter expression cassette; and

two lox sites flanking the repressible CRE expression cassette and the selectable marker cassette.

2. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 1 , wherein the Cas protein is Cas9.

3. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 2 , further comprising an intron inserted into the Cre coding region of the Cre expression cassette.

4. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 3 , wherein the Cas9 expression cassette further comprises a promoter for constitutive expression of Cas9 nuclease.

5. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 4 , wherein the lox sites have the same orientation.

6. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 2 , wherein the alga is a member of the genus Parachlorella.

7. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 2 , wherein the Cas9 expression cassette comprises an N-terminal FLAG tag.

8. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 2 , wherein the selectable market cassette encodes blasticidin resistance.

9. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 8 , wherein the reporter cassette encodes a fluorescent protein.

10. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 1 , wherein the Cas protein is selected from the group consisting of: Cpf1, Csc2, Cas1, Cas2, Cas3, Cas4, and Cas10.

11. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 10 , further comprising an intron inserted into the Cre coding region of the Cre expression cassette.

12. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 11 , wherein the Cas protein expression cassette further comprises a promoter for constitutive expression of the Cas nuclease.

13. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 12 , wherein the lox sites have the same orientation.

14. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 1 , wherein the alga is a member of the genus Parachlorella.

15. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 10 , wherein the Cas protein expression cassette comprises an N-terminal FLAG tag.

16. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 10 , wherein the reporter cassette encodes a fluorescent protein.

17. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 10 , wherein the Cas protein is Cpf1 or Csc2.

18. The fully penetrant RNA-guided endonuclease expressing algal strain of claim 10 , wherein the Cas protein is selected from the group consisting of: Cas1, Cas3, and Cas4.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2026
From: VIRIDOS, INC.
To: PHYKION INC.
Reel/Frame 073421/0601 →
SECURITY INTEREST Recorded Sep 13, 2024
From: VIRIDOS, INC.
To: BREAKTHROUGH ENERGY VENTURES II, L.P.
Reel/Frame 068589/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: VERRUTO, JOHN H.; MOELLERING, ERIC R.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 066171/0130 →
CHANGE OF NAME Recorded Apr 7, 2022
From: SYNTHETIC GENOMICS, INC.
To: VIRIDOS, INC.
Reel/Frame 059631/0684 →
Continuity (3)
Continuation 14986492 · Dec 31, 2015
Provisional Application 62099014 · Dec 31, 2014
Related Publication 20210017530A1 · Jan 21, 2021